Horizon Blue Cross and Blue Shield building in Newark, New Jersey. Photo: Carmen Natale/ALM
A federal appeals court has reinstated an antitrust suit against the Blue Cross Blue Shield Association over claims that the group’s insurance providers conspired to decline coverage for a medical device company’s cardiac monitor.
A unanimous three-judge panel of the U.S. Court of Appeals for the Third Circuit determined in LifeWatch Services v. Highmark that LifeWatch Services had presented enough factual basis to proceed on claims against five insurance plan administrators, including WellPoint, Horizon Blue Cross Blue Shield of New Jersey and Highmark Inc., each of which uses the Blue Cross Blue Shield trademarks.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
